Literature DB >> 19507243

A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism.

Hadar Benyamini1, Hadas Leonov, Shahar Rotem, Chen Katz, Isaiah T Arkin, Assaf Friedler.   

Abstract

We used computational methods to study the interaction between two key proteins in apoptosis regulation: the transcription factor NF-kappa-B (NFkappaB) and the proapoptotic protein ASPP2. The C-terminus of ASPP2 contains ankyrin repeats and SH3 domains (ASPP2(ANK-SH3)) that mediate interactions with numerous apoptosis-related proteins, including the p65 subunit of NFkappaB (NFkappaB(p65)). Using peptide-based methods, we have recently identified the interaction sites between NFkappaB(p65) and ASPP2(ANK-SH3) (Rotem et al., J Biol Chem 283, 18990-18999). Here we conducted a computational study of protein docking and molecular dynamics to obtain a structural model of the complex between the full length proteins and propose a mechanism for the interaction. We found that ASPP2(ANK-SH3) binds two sites in NFkappaB(p65), at residues 236-253 and 293-313 that contain the nuclear localization signal (NLS). These sites also mediate the binding of NFkappaB to its natural inhibitor IkappaB, which also contains ankyrin repeats. Alignment of the ankyrin repeats of ASPP2(ANK-SH3) and IkappaB revealed that both proteins share highly similar interfaces at their binding sites to NFkappaB. Protein docking of ASPP2(ANK-SH3) and NFkappaB(p65), as well as molecular dynamics simulations of the proteins, provided structural models of the complex that are energetically similar to the NFkappaB-IkappaB determined structure. Our results show that ASPP2(ANK-SH3) binds NFkappaB(p65) in a similar manner to its natural inhibitor IkappaB, suggesting a possible novel role for ASPP2 as an NFkappaB inhibitor. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19507243     DOI: 10.1002/prot.22473

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  8 in total

1.  In silico modeling of the cryptic E2∼ubiquitin-binding site of E6-associated protein (E6AP)/UBE3A reveals the mechanism of polyubiquitin chain assembly.

Authors:  Virginia P Ronchi; Elizabeth D Kim; Christopher M Summa; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2017-09-18       Impact factor: 5.157

2.  Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.

Authors:  Robert F Hennigan; Jonathan S Fletcher; Steven Guard; Nancy Ratner
Journal:  Sci Signal       Date:  2019-04-23       Impact factor: 8.192

Review 3.  The selective BH4-domain biology of Bcl-2-family members: IP3Rs and beyond.

Authors:  Giovanni Monaco; Tim Vervliet; Haidar Akl; Geert Bultynck
Journal:  Cell Mol Life Sci       Date:  2012-09-06       Impact factor: 9.261

4.  Analysis of an ankyrin-like region in Epstein Barr Virus encoded (EBV) BZLF-1 (ZEBRA) protein: implications for interactions with NF-κB and p53.

Authors:  David H Dreyfus; Yang Liu; Lucy Y Ghoda; Joseph T Chang
Journal:  Virol J       Date:  2011-09-05       Impact factor: 4.099

5.  Identifications small molecules inhibitor of p53-mortalin complex for cancer drug using virtual screening.

Authors:  Didik H Utomo; Nashi Widodo; M Rifa'i
Journal:  Bioinformation       Date:  2012-05-15

6.  Highly homologous proteins exert opposite biological activities by using different interaction interfaces.

Authors:  Anat Iosub Amir; Martijn van Rosmalen; Guy Mayer; Mario Lebendiker; Tsafi Danieli; Assaf Friedler
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

7.  Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.

Authors:  Xiao-Feng Xie; Qing Yang; Jun Chi; Xian-Zi Yang; Hui-Yun Wang; Guo-Liang Xu
Journal:  Chin J Cancer       Date:  2017-01-19

8.  Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.

Authors:  Shahar Rotem-Bamberger; Chen Katz; Assaf Friedler
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.